AIMCA
RAPT

Alberta Investment Management Corp (AIMCo)’s RAPT Therapeutics RAPT Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,000
Closed -$2.94M – 1347
2021
Q4 		$2.94M Buy
+10,000
New +$2.67M 0.02% 540

Other funds holding RAPT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s RAPT Position: Q1 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of RAPT Therapeutics (RAPT) in Q1 2022, closing a stake of 10,000 shares — an estimated $2.94M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in RAPT in Q4 2021 and held it in 1 quarter. The position peaked at $2.94M in Q4 2021. 85 funds tracked by Wall St. Rank hold RAPT as of Q1 2022.

  • Alberta Investment Management Corp (AIMCo) reported no remaining RAPT Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 10,000 RAPT Therapeutics shares in Q1 2022, an estimated $2.94M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in RAPT Therapeutics in Q4 2021 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s RAPT Therapeutics position peaked at $2.94M in Q4 2021.
  • 85 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2022, filed 16 May 2022.